- Home
- FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA w/o Sodium Bicarbonate, Phenol Red: 1X Liquid
FluxMPS™ DCP-MEM-BR1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) MEM Low Glucose + NEAA formulation with Earle's Salts, engineered for primary fibroblast, neuronal, epithelial and vascular cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. NEAA is pre-loaded to reduce metabolic burden on primary cells, and the formulation omits sodium bicarbonate and phenol red for CO₂-independent, imaging-friendly culture.
- Low Glucose (1.0 g/L, 1000 mg/L) — a physiological carbon source for primary cells sensitive to high-glucose stress
- NEAA pre-loaded (5 amino acids) — reduces de novo synthesis burden and ammonia accumulation in primary cell culture
- Sodium bicarbonate and phenol red both excluded — supports CO₂-independent, HEPES-bufferable, autofluorescence-conscious imaging workflows
- Quadruple-stage filtration train: 0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II — Polish
- Endotoxin release specification < 0.05 EU/mL (USP <85> BET), per manufacturing batch
- Manufactured under an ISO 13485:2016 quality management system with full lot traceability; final QA at Diagnocine, Totowa, NJ
- pH 7.4 (USP <791>); osmolality 235 - 275 mOsm/kg H₂O (USP <785>)
- Glucose1000 mg/L (1.0 g/L, Low Glucose)
- L-Glutamine292 mg/L
- Sodium Pyruvate110 mg/L
- pH (USP <791>)7.4
- Osmolality (USP <785>)235 - 275 mOsm/kg H₂O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2-8°C, protected from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack
Engineered for primary cell culture where standard media fails
MEM with Earle's Salts is the primary cell biologist's medium — but conventional 0.22 µm filtered MEM carries mycoplasma risk, particulates, and endotoxin that can alter primary cell phenotype. FluxMPS™ is filtered to a 0.04 µm final cut-off while preserving the full nutritional profile primary cells depend on.
Microchannel-safe purity
0.04 µm final filtration; USP <788> Method 1 (light obscuration) particulate compliance. Ultra-low particulate primary cell media helps prevent chip channel clogging.
Primary cell–optimized formulation
MEM + Earle's Salts + NEAA: the established standard for primary fibroblasts, neurons, epithelial, and vascular cells.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) supports trace-metal and organic-carbon (TOC) control during manufacture.
Batch-controlled endotoxin specification
< 0.05 EU/mL release specification (USP <85> BET), tested per manufacturing batch. Relevant to TLR4-mediated fibroblast activation, neuroinflammatory signaling, and epithelial barrier studies.
NEAA reduces metabolic burden
Pre-loaded NEAA reduces de novo synthesis burden on primary cells, supporting viability in low-serum conditions and reducing ammonia accumulation.
Customization on demand
pH, glucose, HEPES concentration, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two dedicated prefilter + final-filter pairs — reaching a final 0.04 µm polish.
-
1
0.1 µm Prefiltration I
Large particulate, cell debris and protein aggregate removal; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; provides mycoplasma-retentive filtration (organisms typically 0.2–0.3 µm) beyond what a standard 0.22 µm filter retains.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish.
Performance vs. conventional media
FluxMPS™ DCP-MEM-BR1X is processed through two dedicated prefilter/final-filter pairs reaching a 0.04 µm final cut-off, compared with a single 0.22 µm pass typical of conventional media.
© Diagnocine® — DCP-MEM-BR1X
Primary cell models and OoC applications
FluxMPS™ DCP-MEM-BR1X is purpose-built for primary fibroblasts and related cell models, with 0.04 µm filtration for microfluidic platform compatibility.
Automated Bioreactors & Robotics
A separate 0.01 µm (10 nm) MPS Grade variant is available on request for automated bioreactor and robotic handling systems.
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Reduces micro-fouling risk in delicate chip geometries
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Neuronal Chips & Brain-on-Chip
MEM + Earle’s Salts + NEAA + low glucose provides a physiologically close base for primary cortical neurons, DRG neurons, and iPSC-derived neuronal networks in compartmentalized chips.
Epithelium-on-Chip
Low-glucose MEM with NEAA supports primary epithelial cells and barrier integrity in transwell and microfluidic TEER-monitored platforms.
Primary Fibroblast & Stromal Models
MEM with NEAA is a classical base for primary dermal, lung, and cardiac fibroblasts in low-serum or serum-free OoC conditions.
Vascular Cell Culture
Earle’s salt ionic balance supports vascular smooth muscle cells and primary endothelial co-culture models on vascular-on-chip platforms.
Organ-on-a-Chip & MPS
0.04 µm filtered MEM helps prevent particulate clogging in sub-100 µm neuronal and epithelial chip microchannels.
Low background for imaging
Ultra-low particulate baseline supports confocal microscopy, TEER sensor, and biosensor applications on primary cell chips; phenol red is excluded from this formulation.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] Earle's Salts, [+] NEAA, [+] Low Glucose (1000 mg/L), [+] L-Glutamine, [+] Sodium Pyruvate | [-] Sodium Bicarbonate, [-] Phenol Red |
| Appearance | Pale yellow-colored, clear solution |
| Glucose | 1000 mg/L (1.0 g/L, Low Glucose) |
| NEAA | Present (5 amino acids) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 235 - 275 mOsm/kg H₂O |
| Total ingredients | 35 |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) aseptic fill |
| Parameter | Specification |
|---|---|
| Storage temperature | 2-8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO₂ requirement | CO₂-independent; supplement with HEPES (15-25 mM) for pH buffering |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MEM Low Glucose + NEAA: 35 ingredients verified per lot with CAS numbers where known.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.500 |
| L-Alanine | 56-41-7 | 8.900 |
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 13.300 |
| L-Cystine dihydrochloride | 30925-07-6 | 31.300 |
| L-Glutamic acid | 56-86-0 | 14.700 |
| L-Glutamine | 56-85-9 | 292.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Proline | 147-85-3 | 11.500 |
| L-Serine | 56-45-1 | 10.500 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 2.000 |
| D-Glucose | 50-99-7 | 1000.000 |
| Sodium pyruvate | 113-24-6 | 110.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016-certified facilities. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm, supporting trace-metal and TOC control.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending; Certificate of Analysis for every lot.
Endotoxin — USP <85> BET
LAL assay, assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL per batch.
Particulate — USP <788> Method 1
Light obscuration particle count: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 235 - 275 mOsm/kg H₂O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-MEM-BR1X compares
FluxMPS™ DCP-MEM-BR1X vs. conventional 0.22 µm-filtered MEM Low Glucose + NEAA formulations.
| Parameter | DCP-MEM-BR1X (FluxMPS™) | Conventional MEM Low Glucose (0.22 µm filtered) | Standard DMEM (0.22 µm) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| MEM + NEAA without sodium bicarbonate and phenol red — CO₂-independent, imaging-friendly primary cell base | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 µm stages) | cancel No | cancel No |
| NEAA included | check_circle Yes | Optional add-on | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes (Method 1) | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle Yes (Microfluidics Suitable) | cancel Higher clogging risk | cancel Higher clogging risk |
| Custom formulation | check_circle Available on request | cancel No | cancel No |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-MEM-BR1X.
Supporting literature
Key publications supporting MEM Low Glucose + NEAA in primary cell OoC applications.
- Eagle H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432–437. doi:10.1126/science.130.3373.432
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

